Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Injectable ready-to-use solutions containing an antitumor anthracycline glycoside

Injectable ready-to-use solutions containing an antitumor anthracycline glycoside

US Patent 6107285 · Granted Aug 22, 2000

Estimated economic value: $109,037,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of polyols to obtain stable polymorphous forms of rifaximin2019
Use of polyols to obtain stable polymorphous forms of rifaximin2014
Use of polyols to obtain stable polymorphous forms of rifaximin2012
Therapeutic compositions for intranasal administration which include KETOROLAC2009
Therapeutic compositions for intranasal administration which include KETOROLAC2007
Sustained release pharmaceutical compositions for the parenteral administration 2007
Injectable ready-to-use solutions containing an antitumor anthracycline glycosid2006
Injectable ready-to-use solutions containing an antitumor anthracycline glycosid2006
Injectable ready-to-use solutions containing an antitumor anthracycline glycosid2006
Injectable ready-to-use solutions containing an antitumor anthracycline glycosid2006
Injectable ready-to-use solutions containing an antitumor anthracycline glycosid2006
Injectable ready-to-use solutions containing an antitumor anthracycline glycosid2006